introduction to autonomic pharmacology gloanne c. adolor, rph, md, ms, mba, fpcp
TRANSCRIPT
![Page 1: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/1.jpg)
Introduction to Autonomic Pharmacology
Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP
![Page 2: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/2.jpg)
Outline
• Review of ANS (favorite YL5 subjects)
• Drugs Acting on the ANS– Cholinoceptor-Activating and
Cholinesterase-Inhibiting Drugs– Cholinoceptor-Blocking Agents
Main Reference: Basic and Clinical Pharmacology by Katzung (11th ed).
![Page 3: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/3.jpg)
![Page 4: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/4.jpg)
Autonomic Nervous System (ANS)
• The ANS consists of motor neurons that: – Innervate smooth and cardiac muscle and
glands– Make adjustments to ensure optimal
support for body activities– Operate via subconscious control– Have viscera as most of their effectors
![Page 5: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/5.jpg)
Functions and origins of the ANS
![Page 6: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/6.jpg)
ANS branches• cholinergic fibers - acetylcholine• adrenergic fibers noradrenaline (norepinepherine
NE)
![Page 7: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/7.jpg)
ANS Versus Somatic Nervous System (SNS)
• The ANS differs from the SNS in the following three areas– Effectors– Efferent pathways– Target organ responses
![Page 8: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/8.jpg)
Comparison of Somatic and Autonomic Systems
![Page 9: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/9.jpg)
Efferent Pathways
• Heavily myelinated axons of the somatic motor neurons extend from the CNS to the effector
• Axons of the ANS are a two-neuron chain– The preganglionic (first) neuron has a
lightly myelinated axon– The ganglionic (second) neuron extends to
an effector organ
![Page 10: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/10.jpg)
Effectors
• The effectors of the SNS are skeletal muscles
• The effectors of the ANS are cardiac muscle, smooth muscle, and glands
![Page 11: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/11.jpg)
Efferent (motor) nerves• Two systems
– Autonomic nerves (unconscious)• Eg cardiac output, respiration, etc
– Somatic nerves (voluntary)
![Page 12: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/12.jpg)
Interactions of the Autonomic Divisions
• Most visceral organs are innervated by both sympathetic and parasympathetic fibers
• This results in dynamic antagonisms that precisely control visceral activity
• Sympathetic fibers increase heart and respiratory rates, and inhibit digestion and elimination
• Parasympathetic fibers decrease heart and respiratory rates, and allow for digestion and the discarding of wastes
![Page 13: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/13.jpg)
![Page 14: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/14.jpg)
Role of the Parasympathetic Division
• Concerned with keeping body energy use low• Involves the D activities – digestion, defecation, and
diuresis• Its activity is illustrated in a person who relaxes after
a meal– Blood pressure, heart rate, and respiratory rates are low– Gastrointestinal tract activity is high– The skin is warm and the pupils are constricted
![Page 15: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/15.jpg)
Role of the Sympathetic Division
• The sympathetic division is the “fight-or-flight” system• Involves E activities – exercise, excitement, emergency,
and embarrassment• Promotes adjustments during exercise – blood flow to
organs is reduced, flow to muscles is increased• Its activity is illustrated by a person who is threatened
– Heart rate increases, and breathing is rapid and deep– The skin is cold and sweaty, and the pupils dilate
![Page 16: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/16.jpg)
Visceral Reflexes
Figure 14.7
![Page 17: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/17.jpg)
Action of ANS drugs
• Drugs to block ANS chemical transmission
• Drugs to mimic ANS action• ANS drugs can modify a variety of
effector tissues– Cardiac muscle– Blood pressure– Exocrine glands
![Page 18: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/18.jpg)
Cholinergic transmission
• Acetylcholine is at motor neuron and CNS nerve terminals
• Synthesized from – Acetyl coA (mitochondria) – Choline (dietary)– Catalyzed by choline acetyl transferase (ChAT)
• Release is dependent on Calcium (Ca2+)• Causes muscle contraction
![Page 19: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/19.jpg)
Acetylcholine
• Identified 1921
• Present at all NMJ and also CNS
• Synthesized in the axon terminal
• Diffuses across synaptic cleft
• Two receptor subtypes– Nicotinic ACh receptors– Muscarinic ACh receptors
![Page 20: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/20.jpg)
Neuromuscular Junction
Synaptic End Plate
T.Caceri Veterinary Histology 2003
1999 Sinauer Associates Inc
![Page 21: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/21.jpg)
Acetylcholine and NMJ
![Page 22: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/22.jpg)
Characteristics of a neurotransmitter
• Synthesized in (or transported to) presynaptic terminal
• Stored in vesicles
• Regulated release
• Receptor located on postsynaptic membrane
• Termination of action
![Page 23: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/23.jpg)
Neurotransmitter Effects
• All somatic motor neurons release Acetylcholine (ACh), which has an excitatory effect
• In the ANS:– Preganglionic fibers release ACh– Postganglionic fibers release norepinephrine or ACh and the
effect is either stimulatory or inhibitory– ANS effect on the target organ is dependent upon the
neurotransmitter released and the receptor type of the effector
![Page 24: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/24.jpg)
Synaptic vesicles at the NMJ (EM)
Heuser and Heuser
![Page 25: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/25.jpg)
Presynaptic events
• Calcium influx releases synaptic vesicles from microtubules
• Movement of synaptic vesicles to sites of action
• Interaction of specific proteins• Vesicle docking• Membrane fusion• Calcium dependent exocytosis
![Page 26: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/26.jpg)
Synthesis and release of neurotransmitters
Synaptic Transmission in: Basic Neurochemistry 6 th Edition
![Page 27: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/27.jpg)
Fusion proteins regulate neurotransmitter release
• Vesicle proteins– Synaptobrevin
• Presynaptic membrane proteins– Syntaxins– SNAP-25
![Page 28: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/28.jpg)
The SNARE hypothesis
SNARE (Soluble N’ethylmalemide sensitive fusion Attachment protein REceptor)
A. Pestronk www.neuro.wustl.edu/neuromuscular 2003
![Page 29: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/29.jpg)
![Page 30: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/30.jpg)
![Page 31: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/31.jpg)
Many presynaptic proteins regulate neurotransmitter release
Synaptic Transmission in: Basic Neurochemistry 6 th Edition
![Page 32: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/32.jpg)
Vesicular transport of NT – drug implications
• Toxins targeting neurotransmitter release– Spider venom (excess ACh release)– Botulinum (blocks ACh release)
• Tetanus
![Page 33: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/33.jpg)
Postsynaptic events
• Boutons have multiple nerve terminals• Simultaneous release• Stimulation of contraction via AP• Acetylcholine degraded after action
– ACETYLCHOLINESTERASE (AChE)
![Page 34: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/34.jpg)
RECEPTORS
![Page 35: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/35.jpg)
Cholinergic receptors
• Two classes for acetylcholine• Nicotinic and muscarinic
– Nicotinic are ion channelsIonotrophic
– Muscarinic are G-protein coupled
Metabotrophic
![Page 36: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/36.jpg)
Nicotinic Receptors
• Nicotinic receptors are found on:– Motor end plates (somatic targets)– All ganglionic neurons of both sympathetic
and parasympathetic divisions– The hormone-producing cells of the
adrenal medulla
• The effect of ACh binding to nicotinic receptors is always stimulatory
![Page 37: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/37.jpg)
Muscarinic Receptors
• Muscarinic receptors occur on all effector cells stimulated by postganglionic cholinergic fibers
• The effect of ACh binding: – Can be either inhibitory or excitatory– Depends on the receptor type of the target
organ
![Page 38: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/38.jpg)
Ionotropic AChR
• Consist of five polypeptide subunits
• Receptors vary in:– subunit structure – agonist sensitivity – distribution
• Mediate fast synaptic transmission
![Page 39: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/39.jpg)
Nicotinic AChR are sodium channels
1999 Sinauer Associates Inc
![Page 40: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/40.jpg)
Metabotropic AChR
• Five muscarinic AChR subtypes
• G protein coupled
• Slower synaptic transmission via intracellular signaling cascade
![Page 41: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/41.jpg)
Muscarinic AChR activate G-proteins
1999 Sinauer Associates Inc
![Page 42: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/42.jpg)
Many G proteins for many usesG alpha class Initiating signal Downstream
signal
G alpha s b-Adrenergic amines, glucagon, parathyroid hormone, many others
Stimulates adenylate cyclase
G alpha i Acetylcholine, a-adrenergic amines, many neurotransmitters
Inhibits adenylate cyclase
G alpha t Photons Stimulates cGMP phosphodiesterase
G alpha q Acetylcholine, a-adrenergic amines, many neurotransmitters
Increases IP3 and intracellular calcium
G alpha 13 Thrombin, other agonists
Stimulates Na+ and H+ exchange
![Page 43: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/43.jpg)
G proteins activate enzymes, most commonly the following:
• Adenylyl cyclase - converts ATP into cyclic AMP (cAMP)
• Phospholipase C - cleaves a lipid (inositol phospholipid) into inositol-1,4,5-trisphosphate (IP3, a hydrophilic sugar) and diacylglycerol (DAG, a lipid in the membrane)
![Page 44: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/44.jpg)
Phospholipase C activates 2 signaling pathways
![Page 45: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/45.jpg)
![Page 46: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/46.jpg)
The Organization of the Sympathetic Nervous System
Martini,Fundamentals of Anatomy and Physiology, 5th Edition,Prentice Hall 2001
![Page 47: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/47.jpg)
The Organization of the Sympathetic Nervous System
ThoracicLumbar
Martinit,Fundamentals of Anatomy and Physiology, 5th Edition,Prentice Hall 2001
![Page 48: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/48.jpg)
Sympathetic Synapses
Note location of synapse
![Page 49: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/49.jpg)
The Organization of the Sympathetic Nervous System: The Adrenal Medulla
![Page 50: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/50.jpg)
The Adrenergic Synapse
![Page 51: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/51.jpg)
The Adrenergic Synapse
From: Basic and Clinical Pharmacology 8th edition, B.G. Katzung; Lange 2001
![Page 52: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/52.jpg)
Adrenergic receptors
• Four receptor subtypes 1, 2, 1, 2
• G protein linked– Bind either norepinephrine or epinephrine
![Page 53: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/53.jpg)
Adrenergic Receptors
• The two types of adrenergic receptors are alpha and beta
• Each type has two or three subclasses (1, 2, 1, 2 , 3)
• Effects of NE binding to: – receptors is generally stimulatory– receptors is generally inhibitory
• A notable exception – NE binding to receptors of the heart is stimulatory
![Page 54: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/54.jpg)
Adrenergic Receptors
It will be important to understand how alpha and beta receptorsand the subtypes are distinguished:•Originally by relative potency•Now by cloning
From: Basic and Clinical Pharmacology 8th edition, B.G. Katzung; Lange 2001
![Page 55: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/55.jpg)
Pharmacologic Demonstration of Adrenoreceptor Types
• The existence of alpha and beta receptors was originally proposed by Ahlquist in 1948
• Latter Lands et al 1967, suggested the beta1 beta2 distinction
![Page 56: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/56.jpg)
Adrenergic Receptors
![Page 57: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/57.jpg)
![Page 58: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/58.jpg)
Adrenergic transmission• Catecholamines are the neurotransmitters• Complex synthesis• Secretion at nerve terminals and adrenal glands• Adrenal glands
– Two adrenal glands – Consist of cortex (outer) medulla (inner)
medulla secretes:– Epinephrine (adrenaline) – Norepinephrine
![Page 59: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/59.jpg)
NE and E are released at nerve
terminals and secreted by the adrenal medulla
![Page 60: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/60.jpg)
Norepinephrine and epinephrine
• Catecholamines• Synthesized from dopamine• Present in CNS and sympathetic nerves• Widely distributed, general behavioral
arousal eg raise blood pressure etc• Stress increases release of norepinephrine
![Page 61: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/61.jpg)
Epinephrine targets a G-protein coupled receptor
![Page 62: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/62.jpg)
Beta-adrenergic receptor pathway 1
• On binding of ligand, the receptor activates a G protein.
![Page 63: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/63.jpg)
Dual Innervation
• Most of viscera receive nerve fibers from both parasympathetic and sympathetic divisions
• Both divisions do not normally innervate an organ equally
![Page 64: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/64.jpg)
Dual Innervation
• Antagonistic effects – oppose each other– exerted through dual innervation of same effector
• heart rate decreases (parasympathetic)• heart rate increases (sympathetic)
– exerted because each division innervates different cells
• pupillary dilator muscle (sympathetic) dilates pupil• constrictor pupillae (parasympathetic) constricts pupil
![Page 65: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/65.jpg)
Dual Innervation• Cooperative effects seen when 2 divisions act on different
effectors to produce a unified effect– parasympathetics increase salivary serous cell secretion– sympathetics increase salivary mucous cell secretion
• ANS cooperation is best seen in control of the external genitalia– Parasympathetic fibers cause vasodilation and are responsible for
erection of the penis and clitoris– Sympathetic fibers cause ejaculation of semen in males and reflex
peristalsis in females
![Page 66: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/66.jpg)
Dual Innervation of the Iris
![Page 67: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/67.jpg)
Without Dual Innervation• Some effectors receive only sympathetic
– adrenal medulla, arrector pili muscles, sweat glands and many blood vessels
• Sympathetic tone – a baseline firing frequency– vasomotor tone provides partial constriction
• increase in firing frequency = vasoconstriction• decrease in firing frequency = vasodilation• can shift blood flow from one organ to another as
needed– sympathetic stimulation increases blood to skeletal and cardiac
muscles -- reduced blood to skin
![Page 68: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/68.jpg)
Sympathetic and Vasomotor Tone
Sympathetic division prioritizes blood vessels to skeletal muscles and heart in times of emergency.
Blood vessels to skin vasoconstrict to minimize bleeding if injury occurs during stress or exercise.
![Page 69: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/69.jpg)
Regulation of ANS• Autonomic reflexes control most of activity of
visceral organs, glands, and blood vessels.
• Autonomic reflex activity influenced by hypothalamus and higher brain centers, but it is the hypothalamus that has overall control of the ANS.
• Sympathetic and parasympathetic divisions influence activities of enteric (gut) nervous system through autonomic reflexes.
![Page 70: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/70.jpg)
Levels of ANS Control
• The hypothalamus is the main integration center of ANS activity
• Subconscious cerebral input via limbic lobe connections influences hypothalamic function
• Other controls come from the cerebral cortex, the reticular formation, and the spinal cord
![Page 71: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/71.jpg)
Hypothalamic Control
• Centers of the hypothalamus control:– Heart activity and blood pressure– Body temperature, water balance, and
endocrine activity– Emotional stages (rage, pleasure) and
biological drives (hunger, thirst, sex)– Reactions to fear and the “fight-or-flight”
system
![Page 72: Introduction to Autonomic Pharmacology Gloanne C. Adolor, RPh, MD, MS, MBA, FPCP](https://reader035.vdocuments.site/reader035/viewer/2022062222/5697c0131a28abf838ccc9af/html5/thumbnails/72.jpg)
Levels of ANS Control
Figure 14.9